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The major immediate early (MIE) locus of the Maastricht strain of rat cytomegalovirus (RCMV) was found to comprise five
exons of which the first is noncoding. The first three exons are spliced to either exon 4, generating IE1, or exon 5, generating
IE2. An additional splicing event unique to RCMV (Maastricht) was identified in exon 5, resulting in a 466-bp deletion. IE1
transcripts were detected exclusively during the IE phase of infection in vitro, whereas IE2 transcripts were detected during
both the IE and late phase of infection. The similarities between amino acid sequences derived from the MIE gene of RCMV
(Maastricht) and murine cytomegalovirus are low (22 and 37% for IE1 and IE2, respectively). Surprisingly, the similarities
between the MIE proteins of RCMV (Maastricht) and the England strain of RCMV are also low (23 and 32% for IE1 and IE2,
respectively). This suggests that these RCMV strains represent different betaherpesvirus species rather than strains. This
is underscored by the difference between both viruses in genome size as well as growth characteristics. The existence of
two different RCMV-like species might have important implications for the use of these viruses as models for human
cytomegalovirus. © 1998 Academic Press
INTRODUCTION
Cytomegaloviruses (CMVs) are species-specific beta-
herpesviruses which cause acute, persisting, and latent
infections in both man and animals. Infections of immu-
nocompetent individuals with human CMV (HCMV) are
usually not associated with overt clinical symptoms.
However, infection of immunocompromised individuals
can result in life-threatening disease.
As a model for HCMV infection and disease, we study
the interaction between rat cytomegalovirus (RCMV) and
its host. The RCMV–rat system is a highly suitable model
system, since the pathogenesis of infection in HCMV-
infected humans is similar to that in RCMV-infected rats
(Stals et al., 1990). To date, two strains of RCMV have
been studied: the Maastricht strain (Bruggeman et al.,
1982) and the England strain (Priscott and Tyrrell, 1982).
Interestingly, both RCMV strains differ considerably in
both restriction patterns and size of their genomes; the
genome length was reported to be 224 kilobase pairs
(kb) for the Maastricht strain (Meijer et al., 1986) and 206
kb for the England strain (Burns et al., 1988). Currently,
the nucleotide sequence of approximately 70% of the
genome of RCMV (Maastricht) has been determined
(Beisser et al., 1998; Beuken et al., 1996; Vink et al., 1996,
1997; Vink, Beuken, and Bruggeman, unpublished data).
This sequence information shows that the genome of
RCMV (Maastricht) is collinear with the genomes of mu-
rine CMV (MCMV) as well as HCMV, of which the com-
plete nucleotide sequences have been determined
(Rawlinson et al., 1996; Chee et al., 1990). Additionally,
the predicted amino acid sequences that are derived
from most of the RCMV (Maastricht) open reading frames
(ORFs) display a high level of similarity to the amino acid
sequences derived from ORFs of other CMVs and in
particular MCMV (Beuken et al., 1996; Vink, Beuken, and
Bruggeman, unpublished data). The only sequence infor-
mation that is currently available on the England strain of
RCMV is that of the locus of major immediate early (MIE)
gene transcription (Sandford et al., 1993; Sandford and
Burns, 1996). This locus was found to have an organiza-
tion similar to that of both HCMV and MCMV (Sandford et
al., 1993; Sandford and Burns, 1996). The MIE locus of
RCMV (England) consists of a promoter/enhancer region
that directs transcription of a region consisting of five
exons. These exons are differentially spliced to generate
transcripts encoding two separate proteins, IE1 and IE2.
The IE1 and IE2 transcripts share the first three exons,
the first of which is noncoding. Splicing of these exons to
either exon 4 or 5 generates the IE1 and IE2 transcripts,
respectively (Sandford et al., 1993).
In order to compare the nucleotide sequences from
the Maastricht and England strains of RCMV, we set out
Nucleotide sequence data reported in this paper have been depos-
ited with the GenBank nucleotide sequence database under Accession
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to identify and characterize the MIE locus of the RCMV
(Maastricht) genome. In this report, both the nucleotide
sequence and the transcriptional analysis of the MIE
region are described. Additionally, the predicted amino
acid sequences that are derived from the MIE locus are
compared to those of other CMVs. Surprisingly, the se-
quence of the MIE locus of RCMV (Maastricht) was found
to differ considerably from that of the England strain of
RCMV, such that these viruses should be classified as
different betaherpesvirus species rather than RCMV
strains.
RESULTS
Cloning and sequencing of the MIE locus of RCMV
(Maastricht)
In order to localize a putative MIE locus within the
genome of the Maastricht strain of RCMV, we hypothe-
sized that this locus would be present at a position within
the genome analogous to that of the MIE loci of HCMV
(Chee et al., 1990), MCMV (Rawlinson et al., 1996), and
RCMV (Sandford et al., 1993). This hypothesis followed
the observation that the genome of RCMV (Maastricht) is
collinear with the HCMV and MCMV genomes (Beuken
et al., 1996; Vink et al., 1997; Vink, Beuken, and Brugge-
man, unpublished data). Consequently, we anticipated
the RCMV (Maastricht) MIE locus to be present within
the XbaI F-Y region of the genome (Fig. 1; Meijer et al.,
1986). Thus, each of the XbaI fragments that is contained
within this region was cloned into vector pUC119 and
sequenced. Comparison of the generated nucleotide se-
quences with the MIE sequences of other CMVs indi-
cated that the MIE locus of RCMV (Maastricht) had in-
deed been cloned. The MIE region was found to overlap
three successive XbaI fragments: U, S, and K (Fig. 1). On
the basis of alignments of nucleotide sequences as well
as derived amino acid sequences, a gene structure for
the RCMV (Maastricht) MIE locus was predicted that is
similar to that of the MIE loci of other CMVs (Fig. 1).
Analogous to these loci, the RCMV (Maastricht) MIE
locus might comprise at least five exons encoding two
separate proteins, IE1 and IE2, by alternative splicing of
exons 1–3 to either exon 4 or exon 5, respectively. Interest-
ingly, the nucleotide sequence of the MIE region of the
Maastricht strain of RCMV differs considerably from that of
the MIE region of the England strain of RCMV (50% identity
over a 1296-bp region containing the protein-coding con-
tent of exon 4, as determined by the global alignment
algorithm described by Myers and Miller, 1988). By com-
parison, the identity between this sequence of RCMV
(Maastricht) and the corresponding sequences of HCMV
and MCMV is 48 and 47%, respectively.
It has previously been reported that, in contrast to the
MIE promoter/enhancer regions of HCMV, MCMV, and
simian CMV (SCMV), the corresponding region of the
England strain of RCMV almost completely lacks repet-
itive elements and only contains a limited number of
consensus binding sites for cellular transcription factors
(Sandford and Burns, 1996). However, the Maastricht
strain contains a large number of AP-1 and ATF/CREB
consensus binding sites within the putative promoter/
enhancer region of the MIE locus (MIEP; Fig. 2A). In
addition, this region comprises four copies (A1 to A4) of
a 121-bp direct repeat and three copies (B1 to B3) of a
73-bp direct repeat (Fig. 2B). The sequences of repeats
A1 and B1 are highly similar to those of A2 and B2,
respectively (94 and 99% identity). The sequences of A3
and A4 share only 83 and 50% identity, respectively, with
the A1 sequence. Repeat B3 shares 55% identity with B1.
None of the repeats were found to share significant
sequence similarity with MIEPs of other CMVs. Likewise,
the remaining sequence of the RCMV (Maastricht) MIEP
lacks similarity with sequences of other MIEPs.
Most of the putative AP-1 and ATF/CREB binding sites
are located within the repeat sequences of the RCMV
(Maastricht) MIEP (Fig. 2A). A characteristic that is
shared between the RCMV (Maastricht) MIEP and
MCMV (MIEP) is the large number of potential AP-1
binding sites. Features that are not shared with any of
the other MIEPs are the large number of NF-kB and NF-1
FIG. 1. Restriction map of the RCMV (Maastricht) genome and relative position of the MIE locus. The MIE locus is contained within the XbaI U-K
region of the genome (indicated below the map; Meijer et al., 1986). The position of the predicted exons of the MIE locus are shown as black boxes.
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sites within the sequences of MCMV and SCMV, respec-
tively. As noted by Sandford and Burns (1996), the RCMV
(England) MIEP is unique in its low content of putative
transcription factor binding sites compared to the MIEPs
of other CMVs. However, this sequence was shown to
function as an efficient transcriptional activator (Sand-
ford and Burns, 1996). Whether the corresponding se-
quence from RCMV (Maastricht) is also able to activate
transcription will have to be addressed in future studies.
Structural organization of the MIE locus
To investigate the exon–intron structure of the MIE
region, we subjected transcripts that were produced at
IE times of RCMV infection to reverse transcriptase–PCR
(RT–PCR). The positions and sequences of the primers
that were used in this analysis are listed in Fig. 3A. The
primers were chosen such that the resulting RT–PCR
products would contain the splice junctions between
FIG. 2. Comparison of CMV MIE sequences for known consensus binding sites of cellular transcription factors. (A) The positions of the putative
binding sites were determined by comparing five MIE loci to a database of cellar transcription factors (TRANSFAC; Wingender, 1988) with SIGSCAN
4.05 (Prestridge, 1991). Black boxes indicate exons. (B) Direct repeats within the RCMV (Maastricht) MIE promoter/enhancer region. The sequences
of the direct repeats are shown below the diagram. These repeats can be found under GenBank Asscession No. AF046125 at the following positions:
nucleotides 688 to 808 (A1), nucleotides 882 to 1002 (A2), nucleotides 1076 to 1196 (A3), nucleotides 442 to 560 (A4), nucleotides 809 to 881 (B1),
nucleotides 1003 to 1075 (B2), and nucleotides 592 to 664 (B3). Nucleotides identical to those in the top sequences (A1 or B1) are indicated by periods.
Gaps are represented by a blank space. The numbers at the righthand side indicate the percentages of identity with the sequences at the top.
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FIG. 3. Determination of the RCMV (Maastricht) MIE transcript ends and splice junctions. (A) Positions of DNA probes and positions and sequences
of oligonucleotides that were used in Northern blot hybridization, RACE, and RT–PCR. Black boxes indicate exons. Introns are indicated by open
boxes. Probe positions are indicated by hatched boxes above exons 4 and 5. Primers AAP (59 RACE Abridged Anchor Primer) and AUAP (59 RACE
Abridged Universal Amplification Primer) were supplied by the 59 RACE System for Rapid Amplification of cDNA Ends (Gibco BRL). (B) 59 RACE
products of MIE transcripts. Lane 1 contains a molecular mass reference (100-bp marker). The primer pair combinations that were used are indicated
above lanes 2 and 3. (C) RT–PCR of MIE transcripts. Lanes 1 and 5 contain a molecular mass reference (100-bp marker). The primer pair combinations
that were used in each RT–PCR are indicated above lanes 2–4 and 6–8.
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adjacent exons as predicted in Fig. 1. Except for the 59
RACE protocol, cDNA to be used in PCR was synthesized
using primer 39-RACE1 (Fig. 3A). The 59 ends of tran-
scripts from the MIE region were determined by 59 RACE
as described under Materials and Methods. First, cDNA
was synthesized from IE poly(A)1 RNA using ‘‘gene-
specific’’ primer 3c (Fig. 3A). Then, a poly(C) tail was
added to the 39 end of the cDNA, enabling annealing of
primer AAP, which contains a stretch of G and I residues
at its 39 end. In a subsequent PCR with primers AAP and
2b (which is able to anneal to a sequence within pre-
dicted exon 3), a major DNA fragment was produced with
a length of approximately 500 bp (Fig. 3B, lane 2). This
fragment was subjected to a second PCR with primers
AUAP (which is identical in sequence to the 59 end of
primer AAP) and 1b (which is able to anneal to a se-
quence within predicted exon 2). This amplification re-
sulted in a product of approximately 300 bp (Fig. 3B, lane
3). Similar results were obtained when using primer 3b
instead of primer 3c and L instead of IE poly(A)1 RNA in
cDNA synthesis (data not shown). The length difference
of approximately 200 bp between the first and second
PCR products is in accordance with splicing of predicted
exon 2 to exon 3 (see below). The second, 300-bp 59
RACE product was cloned and sequenced. Similar to the
MIE transcripts of other CMVs, the 59 ends of the RCMV
(Maastricht) MIE transcripts were found to contain a
noncoding leader sequence. This sequence, which was
designated exon 1, has a length of 152 bp and is spliced
to exon 2, which contains an open reading frame (ORF).
The first AUG of this ORF is located 4 nucleotides down-
stream of the 59 boundary of exon 2 (position 2915). In the
RCMV (Maastricht) genome, exons 1 and 2 are separated
by a 954-bp intron, which was termed intron I (Fig. 5A).
To confirm the splicing of predicted exon 2 to exon 3,
PCR amplification of cDNA was carried out with primers
2a and 2b. As shown in Fig. 3C (lane 2), amplification
resulted in a product with a length of 250 bp. The gen-
eration of this RT–PCR product was dependent on the
use of reverse transcriptase during cDNA synthesis, in-
dicating that RNA and not contaminating DNA was am-
plified (data not shown). The length of the 250-bp frag-
ment is in accordance with the presence of the predicted
intron between exons 2 and 3. The nucleotide sequence
of this fragment was determined and revealed an in-
frame fusion between the ORFs of exons 2 and 3. This
indicates that exon 2 is indeed properly spliced to exon
3. The 97-bp intron between exons 2 and 3 was termed
intron II (Fig. 5A).
The predicted splicing of exon 3 to exon 4 was exam-
ined by RT–PCR using primer pairs 3a and 3b. Amplifi-
cation resulted in a product with a length of approxi-
mately 600 bp (Fig. 3C, lane 3). The nucleotide sequence
of this product showed an in-frame fusion between the
ORFs of exons 3 and 4, indicating that exon 3 is indeed
spliced to exon 4. Exons 3 and 4 are separated by an
intron of 97 bp (intron III; Fig. 5A). As discussed above, an
RCMV (Maastricht) IE1 protein might be encoded by a
transcript consisting of exons 1–4. As a consequence,
the 39 end of this transcript might be located near the 39
boundary of exon 4. To investigate this, PCR was per-
formed on cDNA using primers 4a and 39-RACE2. As
shown in Fig. 3C (lane 4), a product with a length of
approximately 800 bp was generated. The sequence of
this product indicated that it did not represent the proper
39 end of the putative IE1 transcript, since it was gener-
ated after annealing of oligonucleotide 39-RACE1 (which
was used in cDNA synthesis) to an internal A-rich stretch
(and not to a 39-terminal poly(A) sequence) at positions
4644 to 4658 within the 39 region of exon 4. Other at-
tempts to efficiently amplify fragments other than the
800-bp product were not successful, probably due to
annealing of primer 39-RACE1 to the internal exon 4
sequence, thereby competing for binding to 39-terminal
poly(A) tails of exon 4 transcripts. Nevertheless, since a
consensus polyadenylation site (59-AATAAA-39) is lo-
cated at positions 4811 to 4816, 113 bp downstream of
the TAG termination codon of exon 4, we hypothesize
that this exon has a length of approximately 1.5 kb. In
conclusion, RCMV (Maastricht) might produce exon 4- or
IE1-specific transcripts consisting of exons 1–4 with a
combined length of at least 1.9 kb.
Splicing of exon 3 to exon 5, which could generate a
putative IE2-specific transcript, was investigated by RT–
PCR using primers 3a and 5b. Interestingly, two major
DNA fragments with respective lengths of approximately
600 and 1.1 kb were produced with this primer pair (Fig.
FIG. 4. Differentially spliced transcripts of the RCMV (Maastricht)
MIE locus emerge during the IE and L phases of infection. The figure
shows autoradiographs of Northern blots that were hybridized with
either an exon 4-specific probe (lanes 1–4) or an exon 5-specific probe
(lanes 5–8). In lanes 1 and 5, mRNA from mock-infected (M) cells was
separated. Lanes 2 and 6 represent the IE phase, lanes 3 and 7 the E
phase, and lanes 4 and 8 the L phase of infection. IE, E, and L phase
mRNA were obtained as described under Materials and Methods. The
estimated lengths of the transcripts are indicated on the outer sides of
the panels in kb.
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3C, lane 6). The length of the larger species is as ex-
pected from splicing of exon 3 to exon 5. The nature of
the 600-bp species, however, was not clear. Since it was
previously reported that the MIE region of HCMV pro-
duces alternative transcripts that have a part of exon 5
deleted (Stenberg et al., 1989), we hypothesized that the
600-bp PCR fragment might represent an alternative
splicing event deleting part of exon 5 from RCMV (Maas-
tricht) MIE transcripts. To investigate this, the 600-bp
fragment was cloned and sequenced. The fragment was
found to contain a splice junction of exons 3 and 5,
resulting in an in-frame fusion of both ORFs. In addition,
the fragment lacked a 466-bp sequence (from positions
4960 to 5425) that is present near the 59 end of exon 5.
This deletion results in a frame shift to an ORF with a
length of only 98 bp (Fig. 5A). To confirm alternative
splicing of exon 5, RT–PCR was also done with two exon
5-specific primers, 5a and 5b. Similarly as described for
primer pairs 3a and 5b, two major DNA fragments were
amplified (Fig. 3C, lane 7). The larger fragment (approx-
imately 950 bp) represents ‘‘full-length’’ exon 5, whereas
the smaller fragment (approximately 500 bp) represents
the alternative splicing product, as confirmed by DNA
sequencing. No evidence was found for splicing of exon
4 to exon 5 using various primer combinations in RT–
PCR (data not shown). This indicates that, similar to the
situation for other CMVs, transcription of the MIE region
of RCMV (Maastricht) generates either exon 4- or exon
5-specific mRNAs, which share exons 1 to 3.
In order to determine the 39 end(s) of the exon 5 tran-
scripts, RT–PCR was carried out with primers 6a and 39-
RACE2. A major product of approximately 650 bp (Fig. 3C,
lane 8) was generated, which was subsequently cloned
and sequenced. Based on the presence of a poly(A) stretch
downstream of exon 5, we inferred that this product indeed
represented the authentic 39 end of an exon 5-specific
transcript. The poly(A) tail followed either nucleotide 6500
or 6501 (which is an A), located at a distance of 26 or 27 bp,
respectively, from a consensus polyadenylation site (59-
AATAAA-39; positions 6469 to 6474). We conclude that
RCMV (Maastricht) expresses at least two exon 5- or IE2-
specific transcripts, which are composed of exons 1–3,
alternatively spliced to either ‘‘full-length’’ exon 5 (resulting
in a transcript termed IE2) or a deleted version of exon 5
(resulting in transcript IE2A). The IE2 and IE2A transcripts
were estimated to have lengths of 2046 and 1580 bp,
respectively. All characterized introns from the MIE locus of
RCMV (Maastricht) were found to share the consensus
sequence GT at their 59 ends and AG at their 39 ends (Fig.
5B; Mount, 1983).
Transcription from the MIE locus
To further investigate transcription from the MIE region
of RCMV (Maastricht), poly(A)1 RNA from RCMV-infected
cells was purified at immediate early (IE), early (E), and
late (L) times of infection of REF. After separation on an
agarose gel, the RNA was transferred to a nylon filter and
hybridized with two different probes. These probes were
used to allow discrimination between putative IE1- and
IE2-specific transcripts and were derived from exons 4
and 5, respectively. As shown in Fig. 4, a single exon
4-specific transcript with a length of approximately 2.5 kb
was observed exclusively at IE times of infection (lane 2).
It is likely that this transcript corresponds to the exon
4-specific transcript that was identified by RT–PCR,
which was estimated to have a length of at least 1.9 kb
(see above). Using the exon 5-specific probe, two differ-
ent major transcripts with respective lengths of approx-
imately 3.5 and 2.0 kb were detected both at IE and L
times of infection (lanes 6 and 8, respectively). An addi-
tional exon 5-specific transcript of 1.6 kb was observed at
L times only (lane 8). The lengths of the 2.0- and 1.6-kb
transcripts correspond with the estimated lengths of the
IE2 and IE2A transcripts, respectively (see above). It is
therefore likely that the 1.9-, 2.0-, and 1.6-kb transcripts
represent transcripts IE1, IE2, and IE2A, respectively. As
a consequence, IE2A would be abundantly expressed
only at L times of infection. However, we were able to
detect the putative IE2A transcript during the IE phase by
RT–PCR (see above). This is probably due to the higher
sensitivity of RT–PCR compared to Northern blot analy-
sis. The structure of the 3.5-kb RNA is not clear. Since
this transcript does not hybridize with an exon 4-specific
probe, it is probably composed of exon 5 sequences as
well as sequences downstream of this exon. The struc-
ture of this 3.5-kb transcript was not subjected to further
studies. A schematic representation of the different mR-
NAs transcribed from the RCMV (Maastricht) MIE locus,
as inferred from the RT–PCR and Northern data, is de-
picted in Fig. 5A. The IE1 transcript has the capacity to
encode a protein with a molecular mass of 61 kDa. The
protein is hydrophilic, containing 16% acidic and 18%
basic amino acids. The calculated isoelectric point of the
IE1 protein is pH 6.8. Two putative nuclear localization
signals (IE1 NLS-1: RKRK, residues 466 to 469; and IE1
NLS-2: KKKQAKKGKKRCKKGKKKCKKE, residues 508 to
529) were found by screening the predicted amino acid
sequence according to a method described by Nakai
and Kanehisa (1992). The IE2 transcript has the potential
to encode a protein with a molecular mass of 68 kDa and
a predicted isoelectric point of pH 8.7. Like IE1, the IE2
protein is hydrophilic, containing 13% acidic and 17%
basic amino acids. Two potential nuclear localization
signals are localized within the predicted IE2 polypeptide
(IE2 NLS-1: KRRGETRSPSPPSSRRRY, residues 284 to
301; and IE2 NLS-2: HRRKPR, residues 379 to 384). The
IE2A protein has the capacity to encode a protein with a
molecular mass of 16 kDa. Similarly to IE1 and IE2, the
IE2A protein is hydrophilic, containing 18% acidic and
11% basic amino acids. The calculated isoelectric point
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of IE2A is pH 4.4. In contrast to the other IE proteins, IE2A
does not possess any nuclear localization signals.
Comparison of the predicted amino acid sequences
of the RCMV (Maastricht) IE proteins with those
of other CMVs
The amino acid sequences that were derived from the
ORFs of the IE1 and IE2 transcripts were compared to
the corresponding sequences of other CMVs. The overall
similarities (Myers and Miller, 1988) between the pre-
dicted amino acid sequences of RCMV (Maastricht) IE1
and those of MCMV (Smith) IE1 and HCMV (AD169) IE72
are 22 and 16%, respectively. As could be expected from
the low level of homology between the MIE regions of
the Maastricht and England strains of RCMV on the DNA
level, the predicted sequences of the IE1 proteins of
these viruses showed an identity of only 23%. When the
sequences of putative IE2-like proteins were compared,
higher identities were seen, indicating that exon 5-like
sequences are more conserved than exon 4-like se-
quences. The identities between the putative IE2 protein
of RCMV (Maastricht) and the corresponding proteins of
MCMV and HCMV are 37 and 27%, respectively. Surpris-
ingly, the identity between the putative IE2 proteins of the
Maastricht and England RCMV strains (32%) is lower
than that between IE2 of RCMV (Maastricht) and ie3 (the
IE2 counterpart) of MCMV. The similarities of IE1 and IE2
amino acid sequences among various CMV strains are
presented in Table 1. To further investigate the relation-
ships between the putative IE proteins of different CMVs
as well as different CMV strains, a phylogenetic tree was
generated using a part of exon 4 of which the nucleotide
FIG. 5. The intron–exon structure of the RCMV (Maastricht) MIE locus. (A) Differentially spliced transcripts from both the HCMV MIE locus
(Rawlinson et al., 1993) and the RCMV (Maastricht) MIE locus. Open boxes indicate untranslated exon regions. Black boxes indicate ORFs. Exons and
introns have been assigned Arabic and Roman numerals, respectively. Phases of infection during which the MIE transcripts can be detected are
indicated at the 39 ends of each transcript. MIEP, major immediate early promotor/enhancer/modulator region. (B) Sequences of splice donor and
acceptor sites. The sequences shown are at the following positions of GenBank Accession No. AF046125: nucleotides 1954 to 1968 (exon 1–intron
I), nucleotides 2901 to 2915 (intron I–exon 2), nucleotides 3012 to 3026 (exon 2–intron II), nucleotides 3102 to 3116 (intron II–exon 3), nucleotides 3303
to 3317 (exon 3–intron III), nucleotides 3393 to 3407 (intron III–exon 4), nucleotides 4895 to 4909 (intron IV–exon 5), nucleotides 4956 to 4970 (exon
5–intron V), and nucleotides 5415 to 5429 (intron V–exon 5).
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sequence of three MCMV strains and three HCMV
strains is known (Fig. 6). On the one hand, this phyloge-
netic tree demonstrates the close relationship among
MCMV strains as well as among HCMV strains. On the
other hand, this tree clearly underlines the considerable
divergence in sequence between RCMV (Maastricht)
and RCMV (England).
In conclusion, both nucleotide sequence and pre-
dicted amino acid alignments strongly suggest that
RCMV (Maastricht) and RCMV (England) are similarly
related to one another as each of these viruses is related
to MCMV. This suggests that these so-called strains of
RCMV actually represent different CMV-like species. As
a consequence, rats might harbor two different CMV-like
viruses, which as yet has not been demonstrated for any
other CMV host.
DISCUSSION
The MIE locus of RCMV (Maastricht) shows a struc-
tural organization similar to those of the corresponding
regions of HCMV, MCMV, and RCMV (England). Each of
these regions consists of differentially spliced genes in
which a noncoding leader sequence (exon 1) is followed
by a large intron (intron I) and four coding exons (exons
2–5) that are separated by small introns (introns II–IV)
(Fig. 5A). Two major IE transcripts of RCMV (Maastricht)
were identified that are similar to IE transcripts of other
CMVs. These transcripts, which were designated IE1
and IE2, share identical 59 ends, consisting of exons 1 to
3, but differ at their 39 ends, having either exon 4 (in IE1)
or exon 5 (in IE2) spliced to the 39 end of exon 3. In both
the IE1 and IE2 transcripts, which have the capacity to
encode proteins of 61 and 68 kDa, respectively, the exon
3 splice donor site is identical (Fig. 5B). Similar to their
counterparts from HCMV (Stenberg et al., 1989; Rawlin-
son and Barrell, 1993) and MCMV (Keil et al., 1987;
Messerle et al., 1992), both IE1 and IE2 of RCMV (Maas-
tricht) are transcribed during the immediate early phase
of infection. During the late phase of RCMV (Maastricht)
infection, IE2 but not IE1 is transcribed, while in the late
phase of HCMV infection both IE1491aa and IE2579aa tran-
scripts are produced (Rawlinson and Barrell, 1993). In
addition to IE1 and IE2 transcripts, we identified a third
major transcript from the RCMV (Maastricht) MIE locus,
which was termed IE2A. This transcript is an IE2-like,
alternatively spliced RNA in which a 466-bp sequence
from exon 5 has been deleted (Fig. 5A). A similar alter-
native splicing event has previously been reported for
the HCMV IE2425aa transcript, in which a 465-bp se-
quence (Fig. 5A) has been deleted from exon 5 (Stenberg
et al., 1989). Interestingly, splicing of IE2425aa of HCMV
TABLE 1
Similarities of IE1 and IE2 Amino Acid Sequences among Various CMV Strains
IE1 similarity (%) IE2 similarity (%)
RCMV-E MCMV-S SCMV-C HCMV-A RCMV-E MCMV-S SCMV-C HCMV-A
RCMV-M 23 22 18 16 32 37 25 27
RCMV-E 26 17 21 34 25 25
MCMV-S 17 21 25 26
SCMV-C 27 45
Note. M, Maastricht (this study); E, England (Sandford et al., 1993); S, Smith (Rawlinson et al., 1996); C, Colburn (Chang et al., 1995); A, AD169 (Chee
et al., 1990). Percentages of similarity were calculated according to the global alignment algorithm described by Myers and Miller (1988).
FIG. 6. The Maastricht and England strains of RCMV are two different
species rather than strains. The phylogenetic tree is based on a
multiple alignment of amino acid sequences that were derived from a
region within exon 4. The alignment was made with amino acid se-
quences that are encoded by the following nucleic acid sequences:
RCMV-M (Maastricht strain), nucleotides 3544 to 3678 of GenBank
Accession No. (GB) AF046125; RCMV-E (England strain; Sandford et al.,
1993), nucleotides 1863 to 1991 of GB L13150; MCMV-G (G1A strain;
Lyons et al., 1996), GB L41001; MCMV-K (K181 strain; Lyons et al., 1996),
GB L41029; MCMV-N (N1 strain; Lyons et al., 1996), GB L41036;
MCMV-S (Smith strain, Rawlinson et al., 1996), the complement of
nucleotides 180972 to 181107 of GB U68299; MCMV-V (Vancouver
strain; Lyons et al., 1996), GB L41001; SCMV-C (simian cytomegalovirus,
Colburn strain; Chang et al., 1995), nucleotides 6652 to 6677 of GB
U38308; HCMV-1 (individual isolate C327MIE; Chou, 1992), nucleotides
144 to 270 of GB M95639; HCMV-2 (individual isolate C327MIE; Chou,
1992), nucleotides 144 to 270 of GB M95638; HCMV-A (AD169 strain;
Chee et al., 1990), the complement of nucleotides 171960 to 172084 of
GB X17403; HCMV-T (Towne strain; Stenberg et al., 1984), nucleotides
154 to 279 of GB M11630. CLUSTAL W pairwise alignment (Thompson
et al., 1994) was set to BLOSUM 30 protein weight matrix, gap open
penalty 5 10, and gap extension penalty 5 0.1. Multiple alignment was
set to BLOSUM series, gap open penalty 5 10, gap extension pen-
alty 5 0.05, delay divergent sequences 5 0.4.
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results in an in-frame deletion, whereas alternative splic-
ing of IE2A of RCMV (Maastricht) results in an out-of-
frame deletion. As a consequence, the 59-terminal 18
codons of exon 5 are coupled to 33 novel codons in the
IE2A transcript, which has the potential to encode a
16-kDa protein (Fig. 5A). By Northern blot hybridization,
an exon 5-specific transcript with a length of 1.6 kb was
identified. Since this length corresponds with the pre-
dicted length of IE2A, we inferred that the 1.6-kb mRNA
represents the IE2A transcript. Interestingly, this mRNA
species was almost exclusively produced at late times of
infection. A late phase-specific transcript from the MIE
locus has previously also been identified for HCMV. This
mRNA is transcribed from a promoter near the 59 end of
exon 5 and encodes an abundant 338-amino-acid protein
(IE2338aa) (reviewed by Mocarski, 1993). The IE2338aa pro-
tein was found to repress expression of HCMV IE or a
genes at late times postinfection. The function of any of
the polypeptides that are predicted to be derived from
the MIE locus of RCMV (Maastricht) will have to come
out of future studies. Nevertheless, on the basis of both
structural and positional similarity between the MIE lo-
cus of RCMV (Maastricht) and that of other CMVs, it is
likely that the RCMV (Maastricht) IE genes play a role in
transcriptional activation of many promoters in a cell-
specific as well as a promoter-specific manner (reviewed
by Mocarski, 1993).
To date, two strains of RCMV are under study, the
Maastricht strain (Bruggeman et al., 1982) and the En-
gland strain (Priscott and Tyrrell, 1982). Unlike strains of
HCMV and MCMV, these RCMV strains were found to
differ considerably in both length and restriction frag-
ment pattern of their genomes (Meijer et al., 1986; Burns
et al., 1988). In addition, these strains showed different
growth characteristics in vitro as well as in vivo. First, the
England strain was found to replicate in rat and mouse
embryo fibroblast cells in vitro to similar levels (Priscott
and Tyrrell, 1982), whereas the Maastricht strain was
found to replicate exclusively in cells from rat origin
(Bruggeman et al., 1982). Second, after infection of lacri-
mal gland acinar epithelial cells in vitro, the England
strain but not the Maastricht strain replicated efficiently
(Huang et al., 1996). Third and most notably, virus could
not be detected in saliva from rats infected with the
England strain (Huang et al., 1996), whereas large
amounts of virus was found in saliva of rats infected with
the Maastricht strain (Bruggeman et al., 1985). We here
show that these differences between RCMV (Maastricht)
and RCMV (England) can be attributed to a considerable
divergence in genome sequence between these viruses.
Minor differences are found when comparing MIE se-
quences from either different MCMV strains or different
HCMV strains (Fig. 6). By contrast, the predicted amino
acid sequences derived from the MIE loci of the Maas-
tricht strain and England strain of RCMV are similarly
related to one another as each of these sequences is
related to the corresponding sequences of MCMV (Fig.
6). Taken together, these data indicate that RCMV (Maas-
tricht) and RCMV (England) represent different betaher-
pesvirus species rather than RCMV strains. Since the
only sequence available of the genome of RCMV (En-
gland) is that of the MIE locus, it is not yet possible to
perform additional sequence comparisons. Currently, ap-
proximately 70% of the genome of RCMV (Maastricht)
has been sequenced (Vink, Beuken, and Bruggeman,
unpublished data). Most of the RCMV (Maastricht) ORFs
that have been identified have counterparts within the
genomes of both HCMV and MCMV. These ORFs share
similarity in sequence as well as relative position within
the genome. Examples of RCMV (Maastricht) genes that
were previously characterized are R33 (Beisser et al.,
1998) and R54 to R57 (Beuken et al., 1996). Each of these
genes was found to have a counterpart at a similar
position in the genomes of HCMV and MCMV. Also, the
sequence directing the initiation of lytic-phase DNA rep-
lication (oriLyt) of RCMV (Maastricht) was found to be
located at a conserved position within the genome (Vink
et al., 1997). It will be interesting to investigate whether a
similar level of conservation exists between the genome
of RCMV (England) and that of other CMVs. Additional
sequence data from the genome of RCMV (England) is
essential in order to classify this virus within the sub-
family of betaherpesviruses.
MATERIALS AND METHODS
Virus and cell culture
Primary REF were used in all infection experiments.
Cells were grown in Eagle’s minimum essential medium
(EMEM; ICN Biomedicals) supplemented with nonessen-
tial amino acids, 2 mM L-glutamine, and 10% newborn
calf serum (NCS). Infection of cells with RCMV (Maas-
tricht) was done essentially as previously described
(Bruggeman et al., 1985).
Cloning and sequencing of the MIE region
Cloning of the XbaI F, U, S, K, O, and Y fragments of the
RCMV genome into vector pSP62-PL has previously
been described (Meijer et al., 1986). Each of these frag-
ments was subcloned into vector pUC119 and both
strands of the plasmid inserts were sequenced using the
Cy5 AutoRead sequencing kit (Pharmacia Biotech) and
an ALFexpress automated DNA sequencer (Pharmacia
Biotech). PCR products were cloned into either vector
pUC119 or pCR2.1 (Invitrogen) and sequenced similarly
as described above. Sequence data were generated
using overlapping plasmid constructs. Sequence analy-
sis was done using the program PC/Gene (version 2.11;
IntelliGenetics).
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Poly(A)1 RNA isolation, reverse transcriptase–PCR
(RT–PCR), and rapid amplification of cDNA
ends (RACE)
Poly(A)1 RNA from RCMV- as well as mock-infected
cells was isolated at IE, E, and L times of infection of REF
using a QuickPrep Micro mRNA Purification Kit (Pharma-
cia Biotech), similarly as previously described (Beisser et
al., 1998). To obtain IE mRNA, REF were treated with 100
mg of cycloheximide/ml 1 h before, during, and 16 h after
infection. During the 1-h infection period, the cells were
exposed to RCMV at a multiplicity of infection (M.O.I.) of
1. E mRNA was isolated after infection of REFs with
RCMV (M.O.I. 5 1) and treatment of the cells with 100 mg
of phosphonoacetic acid/ml from 3 h postinfection (p.i.)
until the cells were harvested at 13 h p.i. L mRNA was
isolated after infection of REF with RCMV at an M.O.I. of
1 and harvesting of cells at 48 h p.i. To obtain mRNA from
mock-infected (M) cells, a similar procedure to that de-
scribed for L mRNA was used, except that RCMV infec-
tion was omitted. Approximately 3 mg of the purified RNA
was treated with DNase I (Pharmacia Biotech), after
which cDNA was synthesized using oligonucleotide
primer 39-RACE1 (Fig. 3A) and a Superscript Plasmid
System for cDNA Synthesis and Plasmid Cloning (Gibco
BRL). As controls, reactions were also performed in the
absence of reverse transcriptase. In order to elucidate
the intron–exon structure of the MIE region, each cDNA
mixture was amplified by PCR using various primer sets.
All primers used are listed in Fig. 3A. To determine the 59
ends of the MIE transcripts, the 59 RACE System for
Rapid Amplification of cDNA Ends (Version 2.0) was used
(Gibco BRL). Primer 3c was used as a gene-specific
primer in order to synthesize first-strand cDNA. After
tailing of the cDNA with dCTP and terminal deoxynucle-
otidyltransferase, PCR was performed using the ‘‘59
RACE Abridged Anchor Primer’’ (AAP; Gibco BRL) and
primer 2b. In a second, nested, PCR, the ‘‘59 RACE
Abridged Universal Amplification Primer’’ (AUAP; Gibco
BRL) and primer 1b were used. The 39 ends of the MIE
transcripts were determined by PCR amplification of
cDNA using primers 4a and 39-RACE2 for IE1-specific
transcripts and primers 6a and 39-RACE2 for IE-2-spe-
cific transcripts. PCR mixtures (50 ml) contained 10 mM
Tris–HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl2, 0.01% Triton
X-100, 0.2 mM each dNTP, 0.5 mM of each primer, 0.1
U/ml Taq DNA polymerase (Pharmacia Biotech), and 2.5
ml of a sevenfold dilution of a cDNA mixture. Amplifica-
tion (5 min at 95°C, 35 cycles of 1 min at 95°C, 1 min at
55°C, and 1 min at 72°C, followed by 10 min at 72°C)
was done in a GeneAmp PCR System 9600 thermal
cycler (Perkin–Elmer).
Cloning of RT–PCR products
All PCR products were purified using MicroSpin
Sephacryl S-400 columns (Pharmacia Biotech). The
PCR fragment that was generated using primers 2a
and 2b was digested with BclI and NcoI, of which the
recognition sites are located near the termini of the
fragment (Fig. 3A). After the generation of blunt ends
by treatment with dNTPs and a DNA polymerase I
Klenow fragment (Klenow; Pharmacia Biotech), the
fragment was cloned into the HinclI site of pUC119.
The PCR fragment that was produced using primers
3a and 3b was cloned in a similar fashion as de-
scribed above, except that the fragment was digested
with other restriction endonucleases, i.e., NcoI and
BstBl. When primers 5a and 5b were used in PCR,
two different fragments were generated with lengths of
479 and 945 bp, respectively. The 479-bp fragment
was treated with dNTPs and T4 DNA polymerase
(Pharmacia Biotech) in order to create blunt ends.
Subsequently, the fragment was cloned into the HinclI
site of pUC119. The 945-bp fragment was also cloned
into the HinclI site of pUC119, after digestion of the
fragment with NotI and Asp718 and subsequent treat-
ment with Klenow. The PCR fragment that was pro-
duced with primers 3a and 5b was cloned directly into
plasmid pCR2.1 (Invitrogen) by using a Eukaryotic TA
Cloning Kit (Invitrogen). The fragment that was gener-
ated by 59 RACE using primers AUAP and 1b was
digested with SalI (the recognition site of which is
located within primer AUAP) and BclI, followed by
treatment with Klenow and cloning into the HinclI site
of pUC119. The products that were generated by PCR
amplification using either primers 4a and 39-RACE2 or
primers 6a and 39-RACE2 were first treated with Kle-
now and then cloned into the HinclI site of pUC119.
Escherichia coli JM83 was used for propagation of all
plasmid constructs.
Northern blot analysis
Poly(A)1 RNA from RCMV- as well as mock-infected
cells was isolated at IE, E, and L times of infection of
REF as described above. Denaturing agarose gelelec-
trophoresis of RNA and transfer to Hybond N mem-
branes (Amersham) has also been described (Beisser
et al., 1998). The integrity of the separated RNA was
confirmed by ethidium bromide staining of agarose
gels and methylene blue staining of filters. To discrim-
inate between IE1 and IE2 transcripts, two probes
were generated that exclusively contain either exon 4
or exon 5 sequences. As an exon 4-specific probe, a
571-bp XbaI–EcoRI fragment was used and as exon
5-specific probe, a 1.5-kb XbaI–NotI fragment was
used; the positions of these fragments within the MIE
region are indicated in Fig. 3A. Labeling of DNA frag-
ments with [a-32P]dATP (ICN) was done using a Ran-
dom Primed DNA labeling kit (Boehringer Mannheim).
Hybridization and autoradiography were performed as
described earlier (Brown and Mackey, 1997).
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